Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113

被引:0
|
作者
Tatsuya Okuno [1 ]
Chigusa Morizane [2 ]
Junki Mizusawa [3 ]
Hiroaki Yanagimoto [4 ]
Satoshi Kobayashi [5 ]
Hiroshi Imaoka [6 ]
Takeshi Terashima [7 ]
Hisato Kawakami [1 ]
Yusuke Sano [3 ]
Takuji Okusaka [2 ]
Masafumi Ikeda [6 ]
Masato Ozaka [8 ]
Haruo Miwa [9 ]
Akiko Todaka [10 ]
Satoshi Shimizu [11 ]
Nobumasa Mizuno [12 ]
Mitsugu Sekimoto [13 ]
Keiji Sano [14 ]
Kazutoshi Tobimatsu [15 ]
Akio Katanuma [16 ]
Kunihito Gotoh [17 ]
Hironori Yamaguchi [18 ]
Hiroshi Ishii [19 ]
Junji Furuse [5 ]
Makoto Ueno [5 ]
机构
[1] Kindai University,Department of Medical Oncology, Faculty of Medicine
[2] Osakasayama City,Department of Hepatobiliary and Pancreatic Oncology
[3] National Cancer Center Hospital,JCOG Data Center/Operations Office
[4] National Cancer Center Hospital,Department of Surgery, Division of Hepato
[5] Kobe University Graduate School of Medicine,Biliary
[6] Kanagawa Cancer Center,Pancreatic Surgery
[7] National Cancer Center Hospital East,Department of Gastroenterology
[8] Kanazawa University Hospital,Department of Hepatobiliary and Pancreatic Oncology
[9] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
[10] Yokohama City University Medical Center,Hepato
[11] Shizuoka Cancer Center,Biliary
[12] Saitama Cancer Center,Pancreatic Medicine Department
[13] Aichi Cancer Center Hospital,Gastroenterological Center
[14] Kansai Medical University Hospital,Division of Gastrointestinal Oncology
[15] Teikyo University School of Medicine,Department of Gastroenterology
[16] Kobe University Graduate School of Medicine,Department of Gastroenterology
[17] Teine Keijinkai Hospital,Department of Surgery
[18] NHO Osaka National Hospital,Department of Surgery
[19] Jichi Medical University,Division of Gastroenterology, Department of Internal Medicine
[20] Chiba Cancer Center,Center for Gastroenterology
关键词
Biliary tract cancers; Chemotherapy; Major hepatectomy;
D O I
10.1007/s10147-024-02642-9
中图分类号
学科分类号
摘要
引用
收藏
页码:83 / 91
页数:8
相关论文
共 50 条
  • [41] Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
    Toyoda, Masanori
    Ajiki, Tetsuo
    Fujiwara, Yutaka
    Nagano, Hiroaki
    Kobayashi, Shogo
    Sakai, Daisuke
    Hatano, Etsuro
    Kanai, Masashi
    Nakamori, Shoji
    Miyamoto, Atsushi
    Tsuji, Akihito
    Kaihara, Satoshi
    Ikoma, Hisashi
    Takemura, Shigekazu
    Toyokawa, Hideyoshi
    Terajima, Hiroaki
    Ioka, Tatsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [42] Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
    Masanori Toyoda
    Tetsuo Ajiki
    Yutaka Fujiwara
    Hiroaki Nagano
    Shogo Kobayashi
    Daisuke Sakai
    Etsuro Hatano
    Masashi Kanai
    Shoji Nakamori
    Atsushi Miyamoto
    Akihito Tsuji
    Satoshi Kaihara
    Hisashi Ikoma
    Shigekazu Takemura
    Hideyoshi Toyokawa
    Hiroaki Terajima
    Satoshi Morita
    Tatsuya Ioka
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1295 - 1301
  • [43] Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients
    Bum Jun Kim
    Changhoon Yoo
    Kyu-pyo Kim
    Jaewon Hyung
    Seong Joon Park
    Baek-Yeol Ryoo
    Heung-Moon Chang
    British Journal of Cancer, 2017, 116 : 561 - 567
  • [44] Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients
    Kim, Bum Jun
    Yoo, Changhoon
    Kim, Kyu-pyo
    Hyung, Jaewon
    Park, Seong Joon
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    BRITISH JOURNAL OF CANCER, 2017, 116 (05) : 561 - 567
  • [45] A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202)
    Hiroaki Yanagimoto
    Hideyoshi Toyokawa
    Daisuke Sakai
    Hiroshi Wada
    Sohei Satoi
    Tomohisa Yamamoto
    Hiroaki Nagano
    Masanori Toyoda
    Tetsuo Ajiki
    Hironaga Satake
    Akihito Tsuji
    Atsushi Miyamoto
    Masanori Tsujie
    Shigekazu Takemura
    Kazuhiro Yanagihara
    Tatsuya Ioka
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 461 - 468
  • [46] A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202)
    Yanagimoto, Hiroaki
    Toyokawa, Hideyoshi
    Sakai, Daisuke
    Wada, Hiroshi
    Satoi, Sohei
    Yamamoto, Tomohisa
    Nagano, Hiroaki
    Toyoda, Masanori
    Ajiki, Tetsuo
    Satake, Hironaga
    Tsuji, Akihito
    Miyamoto, Atsushi
    Tsujie, Masanori
    Takemura, Shigekazu
    Yanagihara, Kazuhiro
    Ioka, Tatsuya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (03) : 461 - 468
  • [47] A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208) Kansai Hepato-Biliary Oncology Group
    Kobayashi, Shogo
    Nagano, Hiroaki
    Tomokuni, Akira
    Gotoh, Kunihito
    Sakai, Daisuke
    Hatano, Etsuro
    Seo, Satoru
    Terajima, Hiroaki
    Uchida, Yoichiro
    Ajiki, Tetsuo
    Satake, Hironaga
    Kamei, Keiko
    Tohyama, Taiji
    Hirose, Tetsuro
    Ikai, Iwao
    Morita, Satoshi
    Ioka, Tatsuya
    ANNALS OF SURGERY, 2019, 270 (02) : 230 - 237
  • [48] Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis
    Lu, Wenjie
    Wang, Lantian
    Li, Xiawei
    Tang, Kezhong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (04)
  • [49] Immuno-histochemical assessment of hENT1 biomarker as a prognostic biomarker for patients undergoing gemcitabine-based chemotherapy for resected biliary tract cancers: A systematic review and meta-analysis
    Bird, N.
    Elmasry, M.
    Elniel, M.
    Fenwick, S.
    Malik, H.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary cancer after failure of gemcitabine plus cisplatin: Retrospective analysis of 321 patients.
    Kang, Jihoon
    Kim, Bumjun
    Yoo, Changhoon
    Hyung, Jaewon
    Kim, Kyu-Pyo
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)